Skip to content

Medpace Holdings, Inc. MEDP Business Segments — Total Revenue

Similar metrics at other companies

BioMarin Pharmaceuticals logo
BMRNReportable Segment — Total revenues
$766.21M+2.8%
Summit Therapeutics logo
SMMTReportable Segment — Revenue
$0
Biogen logo
BIIBReportable Segment — Total Revenue
$2.48B+1.9%
Roivant Sciences logo
ROIVReportable Segment — Revenue
$2.52M-66.7%
Neurocrine Biosciences logo
NBIXReportable Segment — Total revenues
$814.5M+42.2%
Incyte logo
INCYReportable Segment — Total revenues
$1.27B+20.9%

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s business segments — total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s business segments — total revenue?
Medpace Holdings, Inc. (MEDP) reported business segments — total revenue of $706.6M in Q1 2026.
How has Medpace Holdings, Inc.'s business segments — total revenue changed year-over-year?
Medpace Holdings, Inc.'s business segments — total revenue increased by 26.5% year-over-year, from $558.57M to $706.6M.
What is the long-term trend for Medpace Holdings, Inc.'s business segments — total revenue?
Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s business segments — total revenue has grown at a 20.1% compound annual growth rate (CAGR), from $1.46B to $2.53B.
What does business segments — total revenue mean?
The total amount of money generated by the business segment from its core services.
How do you interpret business segments — total revenue?
An increase indicates growing demand for the segment's services and successful market penetration, while a decrease may signal loss of market share or reduced client spending.
How does business segments — total revenue compare across companies?
Standard across all CROs and service-based firms as the primary top-line growth indicator.